Abstract
In the present work, quinaldic acid and chloroacetic acid are used to synthesize Quinolinium 2-Carboxylate 2-Chloroacetic acid (compound 1). Conventionally, the crystal structure of the sample is determined by the single crystal X-ray diffraction method. 1H NMR, 13C NMR, FT-IR, and UV-–visible spectral studies are also carried out to confirm the crystal structure of compound 1. In this respect, compound 1 exhibits inhibitory activity against 1HNY, as evidenced by the molecular docking study. The in silico biological activities are studied, and the results are correlated with the reference drug. Since the molecular structures are optimized, DFT calculations are implemented to find the significant regions for enzymatic activities. The binding affinity values are found for compound 1, which formed an interaction with 1HNY. As evident from the MEP maps, the negative regions are localized over the carboxyl group and are suitable for antidiabetic activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.